The 9 Most Over-the-Top Perks Companies Are Using to Bring Workers Back to the Office

  • 📰 WSJ
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 63%

Switzerland Nachrichten Nachrichten

Switzerland Neuesten Nachrichten,Switzerland Schlagzeilen

Foosball tables and free cold brew are old news. These workplaces have implemented far more interesting strategies.

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/lifestyle/workplace/the-9-most-over-the-top-perks-companies-are-using-to-bring-workers-back-to-the-office-c727461fSTEP RIGHT UP If your office doesn’t feel like a carnival, you might be missing out on some increasingly common amenities.

As long as the job market continues to look strong for workers, Lindemoen doesn’t see these perks going away. In fact, when negotiating for a job prospective employees shouldn’t be shy about inquiring about the perk menu, or asking if certain benefits could be added. Ahead, the most unconventional employee benefits we’ve found in offices across the world.This copy is for your personal, non-commercial use only.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 98. in CH
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competitionBristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »